Ginkgo Bioworks Holdings, Inc. Stock Analysis & AI Score
Ginkgo Bioworks Holdings, Inc. (DNA) has an ST Score of 39.9 (C), driven by its Momentum (B+) and held back by its Forecast (D-). Analysts rate it Buy with a $5.00 price target (-51.2% downside).
Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.
Company Information
| Employees | — |
| CEO | — |
| Sector | Healthcare |
| Industry | Biotechnology |
| IPO Date | — |
| Website | — |
| Country | — |
| Exchange | NYSE |
SEC Filings
Annual Report (10-K)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Quarterly Report (10-Q)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
ST Score
Ginkgo Bioworks Holdings, Inc. (DNA) has an ST Score of 39.9 (C), driven by its Momentum (B+) and held back by its Forecast (D-). Analysts rate it Buy with a $5.00 price target (-51.2% downside).
- Strongest
- MomentumB+
- Weakest
- ForecastD-
All factor grades
- MomentumB+
- ValuationB-
- ProfitabilityB-
- GrowthC+
- SentimentC
- Financial StrengthD+
- ForecastD-
- Piotroski2/9
Contact
DNA stock: frequently asked questions
What is DNA's ST Score?
Ginkgo Bioworks Holdings, Inc. (DNA) has an ST Score of 39.9 (C), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.
Is DNA a buy, hold, or sell?
Analysts rate DNA a Buy, with a price target of $5.00 (-51.2% vs the current price). Our ST Score grades it C (39.9/100). The ST Score is a data-driven signal, not a recommendation.
What are DNA's factor grades?
Valuation B-, Profitability B-, Financial Strength D+, Momentum B+, Growth C+, Forecast D-, Sentiment C.
What is DNA's valuation grade?
Ginkgo Bioworks Holdings, Inc. (DNA) earns a valuation grade of B-, measured against Biotechnology peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.
What is DNA's growth grade?
Ginkgo Bioworks Holdings, Inc. (DNA) earns a growth grade of C+, measured against Biotechnology peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.
What is DNA's profitability grade?
Ginkgo Bioworks Holdings, Inc. (DNA) earns a profitability grade of B-, measured against Biotechnology peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.
What is DNA's financial strength grade?
Ginkgo Bioworks Holdings, Inc. (DNA) earns a financial strength grade of D+, measured against Biotechnology peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.
What is the analyst price target for DNA?
The average analyst price target for Ginkgo Bioworks Holdings, Inc. (DNA) is $5.00 from 11 analysts, which is -51.2% versus the recent price of $10.25.
What is DNA's Piotroski score?
Ginkgo Bioworks Holdings, Inc. (DNA) has a Piotroski F-Score of 2 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.